Synthesis, structures and properties of self-assembling quaternary ammonium dansyl fluorescent tags for porous and non-porous surfaces
作者:Lukasz M. Porosa、Kamlesh B. Mistry、Amanda Mocella、Hellen Deng、Shayan Hamzehi、Alex Caschera、Alan J. Lough、Gideon Wolfaardt、Daniel A. Foucher
DOI:10.1039/c3tb21633k
日期:——
Surface grafted silane, phosphate and benzophenone dansyl molecules.
表面接枝的偶氮基苯基磺酰胺分子。
Chemiluminescence Resonance Energy Transfer Efficiency and Donor–Acceptor Distance: from Qualitative to Quantitative
作者:Jinhui Lou、Xiaofang Tang、Haoke Zhang、Weijiang Guan、Chao Lu
DOI:10.1002/anie.202102999
日期:2021.6
Since its birth in 1967, the utilization of chemiluminescence resonance energytransfer (CRET) has made substantial progress in a variety of fields for its unique features. However, the quantitative relationship between CRET efficiency and donor–acceptor distance has not yet been determined owing to the difficulty in designing the variable lengths between chemiluminescent donors and acceptors. Herein
The magnetic field effects (MFE) on the lifetimes of tripletbiradicals generated from the intramolecular photoreaction of bifunctional chain molecules, α-(4-benzoylphenoxy)-ω-[4-(phenylamino)phenoxy]alkanes (BP–O–n–O–DPA, n=2–16) were studied by laser flash photolysis. MFE on the biradicallifetimes are strongly affected by magnetic field, chain length, and solvent. The effects are interpreted in
Method of using triaryl-ethylene derivatives in the treatment and
申请人:Hoechst Marion Roussel, Inc.
公开号:US05691384A1
公开(公告)日:1997-11-25
The present invention relates to a method of using triaryl-ethylene derivatives in the treatment or prevention bone tissue loss or osteoporosis.
本发明涉及一种在治疗或预防骨组织流失或骨质疏松症中使用三芳基乙烯衍生物的方法。
Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX
作者:Janice E. Chambers、Howard W. Chambers、Kristen E. Funck、Edward C. Meek、Ronald B. Pringle、Matthew K. Ross
DOI:10.1016/j.cbi.2016.07.004
日期:2016.11
behavior with several of the more effective novel oximes, but not 2-PAM. Therefore these novel oximes have demonstrated an ability to reactivate inhibited ChE in brain preparations from two species and in vivo data support their ability to enter the brain and provide a therapeutic action. These novel oximes have the potential to be developed into improved antidotes for nerve agent therapy.